Practical Updates in Cutaneous Squamous Cell Carcinoma: From Disease Biology to Real-World Management

Neil D. Gross, MD, FACS, discusses how anti–PD-1 therapy is changing treatment approaches in advanced CSCC.

Neil D. Gross, MD, FACS, discusses the heterogeneous nature of advanced CSCC.

Vernon Sondak, MD, discusses the importance of accurately distinguishing advanced cutaneous squamous cell carcinoma from basal cell carcinoma.